Page last updated: 2024-10-26

carbonyl cyanide p-trifluoromethoxyphenylhydrazone and Cardiomyopathy, Hypertrophic

carbonyl cyanide p-trifluoromethoxyphenylhydrazone has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone: A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.
carbonyl cyanide p-trifluoromethoxyphenylhydrazone : A hydrazone that is hydrazonomalononitrile in which one of the hydrazine hydrogens is substituted by a p-trifluoromethoxyphenyl group.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brookes, PS1
Zhang, J1
Dai, L1
Zhou, F1
Parks, DA1
Darley-Usmar, VM1
Anderson, PG1

Other Studies

1 other study available for carbonyl cyanide p-trifluoromethoxyphenylhydrazone and Cardiomyopathy, Hypertrophic

ArticleYear
Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:1

    Topics: Animals; Aorta; Ascorbic Acid; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cardiomyopathy, H

2001